Impel Pharms Drug Patent Portfolio
Impel Pharms owns 1 orange book drug protected by 6 US patents Given below is the list of Impel Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11185497 | Intranasal delivery of dihydroergotamine by precision olfactory device | 04 Jan, 2039 | Active |
| US11266799 | In-line nasal delivery device | 05 Nov, 2036 | Active |
| US9919117 | Nozzles for nasal drug delivery | 17 Mar, 2033 | Active |
| US10940278 | Nozzles for nasal drug delivery | 23 Jan, 2033 | Active |
| US10507295 | Nasal drug delivery device | 25 Dec, 2032 | Active |
| US9550036 | Nasal drug delivery device | 05 Sep, 2032 | Active |
Latest Legal Activities on Impel Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Impel Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 11 Jul, 2024 | US9550036 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 11 Jul, 2024 | US10940278 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Apr, 2024 | US11185497 |
|
Email Notification
Critical
| 02 Apr, 2024 | US11185497 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Apr, 2024 | US9550036 |
|
Email Notification
Critical
| 01 Apr, 2024 | US9550036 |
|
Email Notification
Critical
| 29 Mar, 2024 | US10940278 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Mar, 2024 | US10940278 |
|
Email Notification
Critical
| 28 Mar, 2024 | US11266799 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 28 Mar, 2024 | US11266799 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Mar, 2024 | US10507295 |
|
Email Notification
Critical
| 26 Mar, 2024 | US10507295 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 31 May, 2023 | US10507295 |
|
Recordation of Patent Grant Mailed
Critical
| 08 Mar, 2022 | US11266799 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 08 Mar, 2022 | US11266799 |
Impel Pharms's Family Patents
Impel Pharms Drug List
Given below is the complete list of Impel Pharms's drugs and the patents protecting them.
1. Trudhesa
Trudhesa is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11185497 | Intranasal delivery of dihydroergotamine by precision olfactory device |
04 Jan, 2039
(14 years from now)
| Active |
| US11266799 | In-line nasal delivery device |
05 Nov, 2036
(11 years from now)
| Active |
| US9919117 | Nozzles for nasal drug delivery |
17 Mar, 2033
(8 years from now)
| Active |
| US10940278 | Nozzles for nasal drug delivery |
23 Jan, 2033
(8 years from now)
| Active |
| US10507295 | Nasal drug delivery device |
25 Dec, 2032
(8 years from now)
| Active |
| US9550036 | Nasal drug delivery device |
05 Sep, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Trudhesa's drug page